Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Hypermethylation of the miR-137 promoter and negative regulation of miR-137 by CAR contribute in part to reduced miR-137 expression and increased CAR and MDR1 expression in doxorubicin-resistant neuroblastoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP618300.RA2l1UQ5tm4thBk5duNJVOanNLNT4MTlOW7G9Hyvvckwk130_assertion description "[Hypermethylation of the miR-137 promoter and negative regulation of miR-137 by CAR contribute in part to reduced miR-137 expression and increased CAR and MDR1 expression in doxorubicin-resistant neuroblastoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618300.RA2l1UQ5tm4thBk5duNJVOanNLNT4MTlOW7G9Hyvvckwk130_provenance.
• NP869386.RAzLg8Bhm8xkQ0nZqGADAF9b0IqarLKAFNMmbfBCtoDNw130_assertion description "[Hypermethylation of the miR-137 promoter and negative regulation of miR-137 by CAR contribute in part to reduced miR-137 expression and increased CAR and MDR1 expression in doxorubicin-resistant neuroblastoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869386.RAzLg8Bhm8xkQ0nZqGADAF9b0IqarLKAFNMmbfBCtoDNw130_provenance.
• NP1101201.RAe8ypHqCyQBtHXxH6cKXFwjDh8VgLAdb3Z_YD-lbVHUM130_assertion description "[Hypermethylation of the miR-137 promoter and negative regulation of miR-137 by CAR contribute in part to reduced miR-137 expression and increased CAR and MDR1 expression in doxorubicin-resistant neuroblastoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1101201.RAe8ypHqCyQBtHXxH6cKXFwjDh8VgLAdb3Z_YD-lbVHUM130_provenance.
• NP1101204.RAehlaGTHbSKZo2eWbvD6BdqyjR5qdOCMfFdQPUpb15go130_assertion description "[Hypermethylation of the miR-137 promoter and negative regulation of miR-137 by CAR contribute in part to reduced miR-137 expression and increased CAR and MDR1 expression in doxorubicin-resistant neuroblastoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1101204.RAehlaGTHbSKZo2eWbvD6BdqyjR5qdOCMfFdQPUpb15go130_provenance.
• NP1101205.RATVZH6VXi6AP4-MkU3CM7RtgokWNo7NYEjZ5oOoBW9uA130_assertion description "[Hypermethylation of the miR-137 promoter and negative regulation of miR-137 by CAR contribute in part to reduced miR-137 expression and increased CAR and MDR1 expression in doxorubicin-resistant neuroblastoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1101205.RATVZH6VXi6AP4-MkU3CM7RtgokWNo7NYEjZ5oOoBW9uA130_provenance.
• assertion description "[Hypermethylation of the miR-137 promoter and negative regulation of miR-137 by CAR contribute in part to reduced miR-137 expression and increased CAR and MDR1 expression in doxorubicin-resistant neuroblastoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Hypermethylation of the miR-137 promoter and negative regulation of miR-137 by CAR contribute in part to reduced miR-137 expression and increased CAR and MDR1 expression in doxorubicin-resistant neuroblastoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Hypermethylation of the miR-137 promoter and negative regulation of miR-137 by CAR contribute in part to reduced miR-137 expression and increased CAR and MDR1 expression in doxorubicin-resistant neuroblastoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Hypermethylation of the miR-137 promoter and negative regulation of miR-137 by CAR contribute in part to reduced miR-137 expression and increased CAR and MDR1 expression in doxorubicin-resistant neuroblastoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP993515.RAm-_J8p_pSZ5BW9VfLzJbkgKTcmqRc6E6W-Vh0rtgdkA130_assertion description "[Hypermethylation of the miR-137 promoter and negative regulation of miR-137 by CAR contribute in part to reduced miR-137 expression and increased CAR and MDR1 expression in doxorubicin-resistant neuroblastoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP993515.RAm-_J8p_pSZ5BW9VfLzJbkgKTcmqRc6E6W-Vh0rtgdkA130_provenance.
• NP993558.RAusZN0d3qZhVFVt2TFaVWc3dB4mZ1ZNJuERmxh1v8lQU130_assertion description "[Hypermethylation of the miR-137 promoter and negative regulation of miR-137 by CAR contribute in part to reduced miR-137 expression and increased CAR and MDR1 expression in doxorubicin-resistant neuroblastoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP993558.RAusZN0d3qZhVFVt2TFaVWc3dB4mZ1ZNJuERmxh1v8lQU130_provenance.
• NP1101206.RANAI2mhWAnUuIxCY58Ta8b_zJpgEpj83EhGcYnftNtHM130_assertion description "[Hypermethylation of the miR-137 promoter and negative regulation of miR-137 by CAR contribute in part to reduced miR-137 expression and increased CAR and MDR1 expression in doxorubicin-resistant neuroblastoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1101206.RANAI2mhWAnUuIxCY58Ta8b_zJpgEpj83EhGcYnftNtHM130_provenance.
• NP618784.RAnO1dXqvwcY-fk2AIjqrMCgpzPMyREaYmbuUsgJHdsG8130_assertion description "[Hypermethylation of the miR-137 promoter and negative regulation of miR-137 by CAR contribute in part to reduced miR-137 expression and increased CAR and MDR1 expression in doxorubicin-resistant neuroblastoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618784.RAnO1dXqvwcY-fk2AIjqrMCgpzPMyREaYmbuUsgJHdsG8130_provenance.
• NP869038.RArP6FU6FrJGeyIdOGRr5_oYs1ezUXOWlbHs5iP4AX7pc130_assertion description "[Hypermethylation of the miR-137 promoter and negative regulation of miR-137 by CAR contribute in part to reduced miR-137 expression and increased CAR and MDR1 expression in doxorubicin-resistant neuroblastoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869038.RArP6FU6FrJGeyIdOGRr5_oYs1ezUXOWlbHs5iP4AX7pc130_provenance.
• NP1101202.RAq_xbRQJnx2ZrtdL2J7FXhhVzMgVul18LBO4NWRydc58130_assertion description "[Hypermethylation of the miR-137 promoter and negative regulation of miR-137 by CAR contribute in part to reduced miR-137 expression and increased CAR and MDR1 expression in doxorubicin-resistant neuroblastoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1101202.RAq_xbRQJnx2ZrtdL2J7FXhhVzMgVul18LBO4NWRydc58130_provenance.
• NP1101209.RAj1tdxyghaEEji2eMSaZdVUC5I5vs5H58zvrN7FrroeM130_assertion description "[Hypermethylation of the miR-137 promoter and negative regulation of miR-137 by CAR contribute in part to reduced miR-137 expression and increased CAR and MDR1 expression in doxorubicin-resistant neuroblastoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1101209.RAj1tdxyghaEEji2eMSaZdVUC5I5vs5H58zvrN7FrroeM130_provenance.